The interplay between autophagy and the ubiquitin–proteasome system in cardiac proteotoxicity

• Published in: Biochimica et biophysica acta Vol. 1852; no. 2; pp. 188 - 194
• Main Authors: Wang, Changhua, Wang, Xuejun
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.02.2015
• Subjects: Autophagy; Autophagy - drug effects; Heart disease; Humans; Models, Biological; Myocardium - metabolism; Myocardium - pathology; Proteasome Endopeptidase Complex - metabolism; Proteins - toxicity; Proteotoxicity; Ubiquitin - metabolism; Ubiquitin–proteasome system; CHF; LAMP-2A; IHD; ALP; Proteotoxicity; I/R; Autophagy; CryAB; HDAC6; GFP; PFI; CHIP; CTSL; UBA; CMA; UPR; Heart disease; UPS; D7-des; UBL; PQC; GFPu; ER; Ub; Ubiquitin–proteasome system; ERAD; GFPdgn; DRC; 3-MA; IPC
• ISSN: 0925-4439; 0006-3002; 1879-260X
• DOI: 10.1016/j.bbadis.2014.07.028

Proteotoxicity refers to the detrimental effects of damaged/misfolded proteins on the cell. Cardiac muscle is particularly susceptible to proteotoxicity because sustained and severe proteotoxic stress leads to cell death and the cardiac muscle has very limited self-renewal capacity. The ubiquitin–proteasome system (UPS) and the autophagic-lysosomal pathway (ALP) are two major pathways responsible for degradation of most cellular proteins. Alterations of UPS and ALP functions are associated with the accumulation of proteotoxic species in the heart, a key pathological feature of common forms of heart disease including idiopathic, ischemic, and pressure-overloaded cardiomyopathies and a large subset of congestive heart failure. Emerging evidence suggests that proteasome inhibition or impairment activates autophagy and conversely, acute ALP inhibition may sometimes increase intrinsic proteasome peptidase activities but chronic ALP inhibition hinders UPS performance in ubiquitinated protein degradation. The exact molecular basis on which the two degradative pathways interact remains largely undefined. Here we review current understanding of the roles of the UPS and autophagy in the control of cardiac proteotoxicity, with a specific focus on the crosstalk between the two pathways. This article is part of a Special Issue entitled: Autophagy and protein quality control in cardiometabolic diseases. •The ubiquitin–proteasome system degrades protein molecules one by one.•Macroautophagy degrades misfolded proteins in aggregates.•Proteasome impairment activates autophagy for compensation.•Inhibition of autophagy may hinder the performance of the 26S proteasome.•Molecular basis for the interplay between autophagy and the UPS remains unclear.